|
Referenz |
Lieferant |
Beschreibung |
Einheit |
Preis exkl. MwSt. |
|
|
|
USP-1444707 |
USP |
Mitomycin 50 mg |
|
1,409.33 CHF
1,479.80 €
|
|
|
|
USP-1445007 |
USP |
Mitotane 500 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1445018 |
USP |
Mitotane Related Compound A (2,2-Bis(4-Chlorophenyl)-1,1-dichloroethane) 25 mg |
|
1,109.33 CHF
1,164.80 €
|
|
|
|
USP-1445200 |
USP |
Mitoxantrone Hydrochloride 400 mg |
|
1,465.33 CHF
1,538.60 €
|
|
|
|
USP-1445211 |
USP |
Mitoxantrone System Suitability Mixture 0,3 mg |
|
1,614.67 CHF
1,695.40 €
|
|
|
|
USP-1445346 |
USP |
Modafinil Related Compound A - 2-[(diphenylmethyl)sulfinyl]acetic acid 20 mg |
|
1,372.00 CHF
1,440.60 €
|
|
|
|
USP-1445368 |
USP |
Modafinil Related Compound C - 2-[(diphenylmethyl)sulfenyl]acetamide 20 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1445392 |
USP |
Modafinil Sulfone 30 mg |
|
1,372.00 CHF
1,440.60 €
|
|
|
|
USP-1445404 |
USP |
Modafinil CIV (CONTROLLED IN USA) - BACKORDER 200 mg |
|
1,036.80 CHF
1,088.64 €
|
|
|
|
USP-1445415 |
USP |
Modafinil S-enantiomer CIV ((S)-2-(Benzhydrylsulfinyl)acetamide) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) (CONTROLLED IN USA) 30 mg |
|
2,078.40 CHF
2,182.32 €
|
|
|
|
USP-1445426 |
USP |
Moexipril Hydrochloride 100 mg |
|
508.00 CHF
533.40 €
|
|
|
|
USP-1445437 |
USP |
Molindone Related Compound A (3-Ethyl-2-methyl-1,5,6,7-tetrahydro-4H-indol-4-one) 20 mg |
|
1,786.67 CHF
1,876.00 €
|
|
|
|
USP-1445448 |
USP |
Mogroside V 100 mg |
|
1,218.67 CHF
1,279.60 €
|
|
|
|
USP-1445459 |
USP |
Molindone Hydrochloride (HCl) 500 mg |
|
324.00 CHF
340.20 €
|
|
|
|
USP-1445462 |
USP |
Mometasone Furoate Related Compound C (21-Chloro-16alpha-methyl-3,11,20-trioxopregna-1,4-dien-17-yl furan-2-carboxylate) 15 mg |
|
1,649.33 CHF
1,731.80 €
|
|
|
|
USP-1445470 |
USP |
Mometasone Furoate 200 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1445481 |
USP |
Monensin Sodium 200 mg |
|
508.00 CHF
533.40 €
|
|
|
|
USP-1445492 |
USP |
Monk Fruit Extract 500 mg |
|
477.33 CHF
501.20 €
|
|
|
|
USP-1445506 |
USP |
Monobenzone 200 mg |
|
460.00 CHF
483.00 €
|
|
|
|
USP-1445539 |
USP |
USP mAb 001, Monoclonal IgG1 - Biologic - (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) each |
|
1,597.33 CHF
1,677.20 €
|
|
|
|
USP-1445547 |
USP |
USP mAb 002, Monoclonal IgG1 - Biologic - (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) each |
|
1,597.33 CHF
1,677.20 €
|
|
|
|
USP-1445550 |
USP |
Monoclonal IgG System Suitability - Biologic - (COLD SHIPMENT REQUIRED) 2 mg |
|
1,757.33 CHF
1,845.20 €
|
|
|
|
USP-1445571 |
USP |
1-Mononitroglycerin (2,3-Dihydroxypropyl nitrate) 1 mg/mL in Acetonitrile 2 ampoules x 1 mL |
|
1,409.33 CHF
1,479.80 €
|
|
|
|
USP-1445584 |
USP |
2-Mononitroglycerin (1,3-Dihydroxypropan-2-yl nitrate) 1 mg/mL in Acetonitrile 2 ampoules x 1 mL |
|
1,409.33 CHF
1,479.80 €
|
|
|
|
USP-1445595 |
USP |
USP mAb 003, Monoclonal IgG1 - Biologic - (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) each |
|
1,597.33 CHF
1,677.20 €
|
|
|
|
USP-1445608 |
USP |
Moexipril Related Compound A 20 mg |
|
865.33 CHF
908.60 €
|
|
|
|
USP-1445619 |
USP |
Moexipril Related Compound B - ((S)-ethyl 2-{(3S,11aS)-8,9-dimethoxy-3-methyl-1,4-dioxo-3,4-dihydro-1H 20 mg |
|
617.33 CHF
648.20 €
|
|
|
|
USP-1445620 |
USP |
Moexipril Related Compound C (20 mg) ((S)-tert-butyl 2-{(S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate, maleate) 20 mg |
|
617.33 CHF
648.20 €
|
|
|
|
USP-1445631 |
USP |
Moexipril Related Compound D - ((S)-2-{(S)-2-[(S)-4-cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino]propanoyl 20 mg |
|
617.33 CHF
648.20 €
|
|
|
|
USP-1445642 |
USP |
Moexipril Related Compound E - ((S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hy 20 mg |
|
617.33 CHF
648.20 €
|
|
|
|
USP-1445653 |
USP |
Moexipril Related Compound F 20 mg |
|
1,746.67 CHF
1,834.00 €
|
|
|
|
USP-1445664 |
USP |
Moexipril Related Compound G - ((S)-6,7-dimethoxy-2-{(S)-2-[(S)-1-methoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hydrochloride) 20 mg |
|
617.33 CHF
648.20 €
|
|
|
|
USP-1445925 |
USP |
Monoethanolamine 1 mL |
|
533.33 CHF
560.00 €
|
|
|
|
USP-1446000 |
USP |
Monoglycerides 125 mg |
|
438.67 CHF
460.60 €
|
|
|
|
USP-1446600 |
USP |
Monosodium Glutamate 500 mg |
|
868.00 CHF
911.40 €
|
|
|
|
USP-1446804 |
USP |
Monostearyl Maleate 100 mg |
|
1,589.33 CHF
1,668.80 €
|
|
|
|
USP-1446815 |
USP |
Montelukast Dicyclohexylamine 150 mg |
|
1,581.33 CHF
1,660.40 €
|
|
|
|
USP-1446837 |
USP |
Montelukast for Peak Identification (Mixture of montelukast dicyclohexylamine (91.7%), sulfoxide impurity (0.3%), Michael adducts 1 and 2 impurity (2.5%), methylketone impurity (2.7%), and methylstyrene impurity (1.6%)) 20 mg |
|
1,604.00 CHF
1,684.20 €
|
|
|
|
USP-1446848 |
USP |
Montelukast Racemate 20 mg |
|
1,604.00 CHF
1,684.20 €
|
|
|
|
USP-1446859 |
USP |
Montelukast Sodium (Sodium 1-[[[(R)-m-[(E)-2-(7-chloro-2-quinolyl)vinyl]-alpha-[o-(1-hydroxy-1-methylethyl)phenethyl]benzyl]thio]methyl]cyclopropaneacetate) 50 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1446906 |
USP |
Morantel Tartrate 100 mg |
|
460.00 CHF
483.00 €
|
|
|
|
USP-1446950 |
USP |
Moricizine Hydrochloride (HCl) 250 mg |
|
568.00 CHF
596.40 €
|
|
|
|
USP-1447002 |
USP |
Morphine Monohydrate CII (50 mg) (AS) (CONTROLLED IN GERMANY) 50 mg |
|
803.20 CHF
843.36 €
|
|
|
|
USP-1448005 |
USP |
Morphine Sulfate CII (7,8-didehydro-4,5alpha-epoxy-17-methylmorphinian-3,6alpha-diol sulfate (2:1) (salt) pentahydrate)(CONTROLLED IN GERMANY) 500 mg |
|
1,304.00 CHF
1,369.20 €
|
|
|
|
USP-1448016 |
USP |
Morphine Related Compound A CI (20 mg) (Morphine N-Oxide) (CONTROLLED IN GERMANY) 20 mg |
|
1,940.80 CHF
2,037.84 €
|
|
|
|
USP-1448027 |
USP |
Morphine Related Compound B (2,2'-Bimorphine trihydrate) CII (CONTROLLED IN USA) 20 mg |
|
1,940.80 CHF
2,037.84 €
|
|
|
|
USP-1448559 |
USP |
Moxidectin (200 mg) 200 mg |
|
734.67 CHF
771.40 €
|
|
|
|
USP-1448560 |
USP |
Moxidectin System Suitability Mixture 50 mg |
|
1,574.67 CHF
1,653.40 €
|
|
|
|
USP-1448606 |
USP |
Moxifloxacin Hydrochloride ((1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3- quinolinecarboxylic acid, monohydrochloride monohydrate)) 200 mg |
|
1,221.33 CHF
1,282.40 €
|
|
|
|
USP-1448617 |
USP |
Moxifloxacin Related Compound A - 1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 25 mg |
|
1,568.00 CHF
1,646.40 €
|
|
